Kaiming Xu
- Co-authors
- Hui‐Kuo G. ShuThomas J. MurphyT J MurphyLanfang WangHuiying GaoChide HanXiaofei WangValerie Boss
- Topics
- Inflammatory mediators and NSAID effects (6 papers)Receptor Mechanisms and Signaling (4 papers)Eicosanoids and Hypertension Pharmacology (3 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Kaiming Xu
21 papers receiving 577 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 309
- Oncology 124
- Pharmacology 113
- Cancer Research 97
- Immunology 85
Countries citing papers authored by Kaiming Xu
This map shows the geographic impact of Kaiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Xu more than expected).
Fields of papers citing papers by Kaiming Xu
This network shows the impact of papers produced by Kaiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Xu. The network helps show where Kaiming Xu may publish in the future.
Co-authorship network of co-authors of Kaiming Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Kaiming Xu. A scholar is included among the top collaborators of Kaiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiming Xu. Kaiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 42 | |
| 5 | 26 | |
| 6 | 21 | |
| 7 | 70 | |
| 8 | 48 | |
| 9 | 20 | |
| 10 | 25 | |
| 11 | 13 | |
| 12 | 14 | |
| 13 | 48 | |
| 14 | 23 | |
| 15 | 4 | |
| 16 | 27 | |
| 17 | 42 | |
| 18 | 23 | |
| 19 | 13 | |
| 20 | 10 |
About Kaiming Xu
Kaiming Xu is a scholar working on Biochemistry, Pharmacology and Cancer Research, having authored 22 papers that have together received 589 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Receptor Mechanisms and Signaling (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (113 citations), Cancer Research (97 citations) and Biochemistry (42 citations). Kaiming Xu has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Hui‐Kuo G. Shu, Thomas J. Murphy, T J Murphy, Lanfang Wang, Huiying Gao, Chide Han, Xiaofei Wang, Valerie Boss, Youyi Zhang and Younghyoun Yoon. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.